Shannon Devens, MS
Shannon Devens, MS
Chief Development Officer
Shannon Devens joined Clasp Therapeutics as Chief Development Officer in January 2024. She most recently was Senior Vice President, Development Operations and a member of the executive team at Surface Oncology, Inc. before its acquisition by Coherus Biosciences. Prior to Surface, Shannon served as the Head of Clinical Operations at Infinity Pharmaceuticals. Earlier in her career, she worked at Molecular Insight Pharmaceuticals, Dyax Corp. and Brigham & Women’s Hospital/Harvard Medical School. Shannon has a B.A. in English from the University of Colorado Boulder and an M.S. in Cardiopulmonary and Exercise Science from Northeastern University.